The Tumorigenesis and Molecular Cancer Prevention (Nowicki-Osuch) lab at the German Cancer Research Centre (DKFZ) in Heidelberg focuses on the development of experimental and computational methods for the analysis of solid tumors in three dimensions. We focus our attention on early stages of gastro-esophageal cancer cancer development. The lab collaborates with the New York Genome Center, Columbia University and Cambridge University.

News and Spotlights

  • 01/07/2023: We have moved to Germany! Nowicki-Osuch lab is now part of German Cancer Resrach Center! Read more here

  • 02/06/2023: We happy to share out new study that aims to show Stomach and Esophageal pre-cancerous lesions are similar! Read more here

  • 03/03/2023: We are now formally part of CSNCG! Exciting science related to the “dark genome” is coming. Read more here

  • 06/02/2023: We are coming to AGBT! Visit our poster (525) on Tuesday or Wednesday.

  • 19/09/2022: The Nowicki-Osuch lab receives a multi-PI R01 grant. Read more.

  • 12/04/2022: Jack Yang, intern in the Nowicki-Osuch lab, shares about his career path and his personal stories. Read more.

  • 01/02/2022: Canada UK Foundation Supports the Deployment of Canadian Technology to Cancer Labs

  • 12/08/2021: Publication in Science “Molecular phenotyping reveals the identity of Barrett’s esophagus and its malignant transition” is out. Read more here: University of Cambridge press release, IICD spotlight, Editorial in Science.

  • 30/10/2020: Spotlight Karol Nowicki-Osuch by Canada UK Foundation: watch the video here.